Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Tirzepatide is a dual agonist targeting both GLP-1 and GIP receptors, improving insulin sensitivity and promoting fullness, leading to superior weight losssome patients lose over 20%, with an average of 15%
Retatrutide is a once-weekly injection still in clinical trials -but early results (up to 24% body weight loss in 11 months ) are drawing comparisons to bariatric surgery
Risks of Obesity: The Dark Side of the Story Behind the curtain, obesity is a villain with a twisted backstory
Funch, D
US$ 28.24
US$ 20.06
US$ 21.04
US$ 22.96
US$ 22.59
US$ 25.65
